Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Front Public Health ; 12: 1361509, 2024.
Article in English | MEDLINE | ID: mdl-38756889

ABSTRACT

Introduction: Gynecologists and pediatricians have an essential duty to prevent cervical cancer. In this study, we compared the compliance of gynecologists (n = 22) and pediatricians (n = 49) with nurse/midwife (n = 66) and non-medical moms (n = 120) with regards to cervical cancer precautions. Methods: A questionnaire was used to gather data on their demographics, personal vaccination and screening practices, children's immunization status, and awareness of cervical cancer prevention. Results: The findings demonstrated that gynecologists and pediatricians were better than others at understanding the risk factors and prevention of cervical cancer. It was noted that compared to other groups, physician mothers and their offspring had higher vaccination rates (n = 13, 18.3%; n = 10, 29.4%, respectively). Medical professionals typically provided thorough and accurate answers to informational questions. More frequent Pap smear tests were performed by gynecologists. It was noted that mothers who worked as pediatricians and nurses/midwives neglected their own screening needs. Discussion: This questionnaire survey sought to ascertain Istanbul's health professionals' present opinions regarding HPV vaccination. Healthcare professionals should be the first to receive information on HPV vaccination and cervical cancer incidence reduction. The public could then readily use them as an example.


Subject(s)
Health Knowledge, Attitudes, Practice , Mothers , Papillomavirus Vaccines , Pediatricians , Uterine Cervical Neoplasms , Humans , Female , Turkey , Surveys and Questionnaires , Adult , Uterine Cervical Neoplasms/prevention & control , Mothers/statistics & numerical data , Mothers/psychology , Papillomavirus Vaccines/administration & dosage , Pediatricians/statistics & numerical data , Pediatricians/psychology , Nurses/statistics & numerical data , Nurses/psychology , Papillomavirus Infections/prevention & control , Middle Aged , Gynecology/statistics & numerical data , Male , Gynecologists
2.
Postgrad Med ; 135(8): 824-830, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37997766

ABSTRACT

OBJECTIVE: To reveal the vaccination status of patients with pediatric rheumatic disease (PedRD) and to compare this with healthy controls. METHODS: The electronic health records of the Ministry of Health regarding the vaccination status of children with PedRD followed in a tertiary hospital were analyzed cross-sectionally and compared with their healthy controls. The missing vaccines were reported according to individual, age-appropriate schedule and causes of skipped vaccines in both groups were investigated with an online survey. RESULTS: The vaccination rate of patients in the last examination was 71.4% (90/126) and 95.7% (110/115) in healthy controls (p < 0.001). Measles-mumps-rubella vaccine, diphtheria, the administration rates of the second dose of tetanus-acellular pertussis-inactivated polio and Haemophilus influenzae type B, chickenpox, and hepatitis A vaccines were significantly lower in patients than in controls (p values 0.004, 0.02, 0.01, 0.013, respectively). The pre-diagnosis incomplete vaccination proportion was significantly higher in the patient group (16.6%) than in healthy controls (4.3%) (p = 0.002). In the patient group, the proportion of incomplete live-attenuated vaccines after diagnosis (25%) was more than pre-diagnosis (61.1%) (p = 0.04), while the proportion of incomplete non-live vaccines before and after diagnosis was similar (47.2% and 50%, respectively) (p = 0.73). The major reasons for missed vaccines were physicians' recommendations (15.6%), the presence of PedRD diagnosis (12.5%), and the drugs used (12.5%). CONCLUSION: Vaccination coverage of PedRD patients has been shown to lag behind the routine vaccination schedule (71.4%). In addition to new recommendations, electronic health system records for vaccination may be appropriate for the follow-up of these patients, and the addition of reminder alerts may be useful to reduce the rate of missed vaccinations.


Subject(s)
Diphtheria-Tetanus-Pertussis Vaccine , Vaccination Coverage , Humans , Child , Infant , Retrospective Studies , Case-Control Studies , Vaccination
3.
Eur J Pediatr ; 182(1): 135-140, 2023 Jan.
Article in English | MEDLINE | ID: mdl-36224436

ABSTRACT

To evaluate the safety profile of measles, mumps and rubella (MMR) booster in children diagnosed with rheumatic diseases receiving biological agents. The study included retrospective safety data of children administered MMR booster dose receiving biologics or biologics with methotrexate. The files of 182 patients were accessed from the pediatric rheumatology biological therapy archive, and the vaccination status of these children was obtained by accessing electronic records. Of 182 patients, 14 patients were vaccinated with MMR booster dose. Thirteen of the patients were followed up with a diagnosis of juvenile idiopathic arthritis and one with colchicine-resistant familial Mediterranean fever. None of the patients had disease exacerbation after vaccination, and three patients had mild side effects consisting of rash, angioedema, joint pain, and fatigue.    Conclusion: This study supports the data regarding evidence of the safety of MMR booster dose administration in children with rheumatic diseases receiving bDMARDs. What is Known: • MMR booster is avoided in immunocompromised pediatric patients receiving bDMARDs except in specific conditions. What is New: • The MMR booster dose may be safe in children with PedRD receiving bDMARDs or bDMARDs with MTX. These bullets can be added to the manuscript.


Subject(s)
Arthritis, Juvenile , Measles-Mumps-Rubella Vaccine , Measles , Mumps , Rubella , Child , Humans , Infant , Antibodies, Viral/therapeutic use , Arthritis, Juvenile/drug therapy , Measles/prevention & control , Measles-Mumps-Rubella Vaccine/adverse effects , Methotrexate/therapeutic use , Mumps/prevention & control , Retrospective Studies , Rubella/prevention & control , Immunization, Secondary
4.
J Pediatr Hematol Oncol ; 45(3): e370-e377, 2023 04 01.
Article in English | MEDLINE | ID: mdl-36044327

ABSTRACT

Despite developing consensus guidelines addressing immunization after hematopoietic stem cell transplantation (HSCT), studies showed deviations from recommended immunization practices commonly occur. Difference between the ideal scenario presented in guidelines and real-life scenarios is one of the most recognized barriers to implementing recommended practices. Therefore, this study aimed to evaluate pediatric allogeneic HSCT recipients' adherence to revaccination schedule and evaluate the serological status after immunization. Transplant and vaccination records of children who were followed up at least 2 years after HSCT, postvaccination antibody results of vaccine-preventable diseases were evaluated retrospectively. Total of 173 patients have enrolled in this study. Median revaccination onset time was post-transplant 15 months. Adherence to revaccination program was 30% for inactive and 11.4% for live vaccines. Oral polio vaccine was given to 22 patients, and Bacille-Calmette-Guerin vaccine was applied to 3. Seropositivity after revaccination was >90% for Hepatitis B, Hepatitis A, pertussis, and measles, and it was 88.5% for rubella, 80% for mumps and varicella. Measles seropositivity was low in children with hemoglobinopathy. In subgroup assessments of pertussis, patients vaccinated with low antigen-containing pertussis vaccine (Tdap) had higher seropositivity of adenylate cyclase toxin. Our findings revealed the importance of careful monitoring of current practices in pediatric HSCT recipients.


Subject(s)
Hematopoietic Stem Cell Transplantation , Measles , Whooping Cough , Child , Humans , Retrospective Studies , Vaccination , Vaccines, Attenuated
5.
Turk J Med Sci ; 47(3): 817-825, 2017 Jun 12.
Article in English | MEDLINE | ID: mdl-28618728

ABSTRACT

BACKGROUND/AIM: Understanding the causes of under-five deaths is key to realizing sustainable developmental goals. The aim of this descriptive study was to investigate the causes of under-five mortality in Istanbul during 2011 and compare the findings to those of 1988 and 2000. MATERIALS AND METHODS: All burial records of Istanbul were evaluated, and cemetery records of 1494 children, who died at under five years of age and were buried in Istanbul Metropolitan Municipality Cemeteries between 1 January and 31 December 2011, were analyzed. Several sociodemographic characteristics and causes of death were compared with the results of studies carried out in 1988 and 2000 in Istanbul with similar methods. RESULTS: Under-five mortality rate was lower in 2011 than in 1988 and 2000. Of all deaths, 58.8% had occurred in the neonatal period and most were in the first day of life, similarly to those of 1988 and 2000. The proportion of deaths in the age group of 1-4 years was found to be increasing. Prematurity and perinatal causes remained the main cause of death under five years of age in Istanbul during the 23-year period. Unknown causes, due to misclassification, were still seen in a relatively high proportion. CONCLUSION: Under-five mortality rate and death due to infectious diseases decreased in Istanbul from 1988 to 2011. Our findings showed a need for more emphasis on perinatal events and better evaluation of causes of death in clinical practice.


Subject(s)
Cause of Death , Child Mortality , Infant Mortality , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , Pakistan/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...